Physician profile
Lee Walker
NPI 1417044348
$1,023.49
in general payments reported to CMS, 2019-2025
19 companies · $94.26 in 2025
The $94.26 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $136 · 2020: $259 · 2021: $245 · 2022: $198 · 2023: $66.69 · 2024: $25.11 · 2025: $94.26.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $186.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $186.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $205.79 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $145.78 | 2019-2025 | Farxiga, Airsupra |
| Abbott Laboratories | $143.72 | 2021-2023 | Freestyle Libre 3 |
| Getinge USA Sales, LLC | $69.50 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $69.37 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $60.32 | 2019-2022 | |
| Lilly USA, LLC | $51.69 | 2020-2023 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $44.98 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $41.94 | 2022 | |
| Abbvie INC. | $27.90 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.79 | 2019-2021 | |
| Horizon Therapeutics Plc | $24.00 | 2019 | |
| Janssen Pharmaceuticals, INC | $20.18 | 2019 | |
| Evoke Pharma, INC. | $19.31 | 2021 | |
| Exact Sciences Corporation | $17.28 | 2025 | Cologuard Collection Kit |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $14.04 | 2021 | |
| Sanofi Pasteur INC. | $13.60 | 2020 | |
| Shield Therapeutics INC | $13.33 | 2023 | Accrufer |
| Nabriva Therapeutics, Plc | $12.97 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lee Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.